Regencell Bioscience Holdings annual total assets
2020
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Total Assets Growth & History (RGC)
Regencell Bioscience Holdings's total assets was $5.8M for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $5.8M | −$2.7M | −31.79% |
| 2024 | 2024-06-30 | $8.4M | −$4.2M | −33.15% |
| 2023 | 2023-06-30 | $12.6M | −$5.4M | −29.95% |
| 2022 | 2022-06-30 | $18.0M | $17.7M | +5197.59% |
| 2021 | 2021-06-30 | $340,134 | −$173,884 | −33.83% |
| 2020 | 2020-06-30 | $514,018 | — | — |
Regencell Bioscience Holdings quarterly total assets
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | $3.0M | −$4.5M | −59.71% |
| Q4 2025 | 2025-06-30 | $5.8M | −$2.7M | −31.79% |
| Q2 2025 | 2024-12-31 | $7.5M | — | — |
| Q4 2024 | 2024-06-30 | $8.4M | −$4.2M | −33.15% |
| Q4 2023 | 2023-06-30 | $12.6M | −$5.4M | −29.95% |
| Q4 2022 | 2022-06-30 | $18.0M | $17.7M | +5197.59% |
| Q4 2021 | 2021-06-30 | $340,134 | −$173,884 | −33.83% |
| Q4 2020 | 2020-06-30 | $514,018 | — | — |
Regencell Bioscience Holdings total assets trends
Over the last five fiscal years, Regencell Bioscience Holdings's total assets increased from $514,018 to $5.8M, a change of $5.2M. The latest reported quarter, Q2 2026, shows $3.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗